Trials / Completed
CompletedNCT05117671
Is the EBJIS Definition of Prosthetic Joint Infection Meaningful in Our Clinical Practice?
Is the EBJIS Definition of Prosthetic Joint Infection Meaningful in Our Clinical Practice? - a Multicentric Validation Study
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,554 (actual)
- Sponsor
- University Hospital, Basel, Switzerland · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- Not accepted
Summary
This retrospective multi-center, multi-national cohort study is to validate the European Bone and Joint Infection Society (EBJIS) Definition of Prosthetic Joint Infection. Specifically, it is to analyze the outcome of the Infection Likely group and compare it to the Infection Unlikely group as well as other subgroups within previous validated definitions (Musculoskeletal Infection Society (MSIS)/International Consensus on Musculoskeletal Infection (ICM) 2013 and ICM 2018).
Detailed description
Periprosthetic joint infection (PJI) is a major burden for healthcare systems. The European Bone and Joint Infection Society (EBJIS) proposed a new set of criteria introducing a three level 'traffic light' distinction: Infection Unlikely, Infection Confirmed but also an intermediate group called Infection Likely (but nor confirmed). This retrospective multi-center, multi-national cohort study is to validate the EBJIS Definition of Prosthetic Joint Infection. Specifically, it is to analyze the outcome of the Infection Likely group and compare it to the Infection Unlikely group as well as other subgroups within previous validated definitions (Musculoskeletal Infection Society (MSIS)/International Consensus on Musculoskeletal Infection (ICM) 2013 and ICM 2018).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | data collection to classify infection status | Review of medical records of all selected cases (TKA/THA patients) to classify infection status according to different classifications (EBJIS, MSIS/ICM 2013, ICM 2018). |
Timeline
- Start date
- 2021-04-16
- Primary completion
- 2021-08-16
- Completion
- 2021-10-19
- First posted
- 2021-11-11
- Last updated
- 2024-02-28
Locations
2 sites across 2 countries: Portugal, Switzerland
Source: ClinicalTrials.gov record NCT05117671. Inclusion in this directory is not an endorsement.